Endothelial Cells Actively Control Body's Fat Metabolism and Energy Storage
Background
Endothelial cells, which line blood vessels, are increasingly recognized as active participants in systemic lipid metabolism, rather than merely passive conduits. Traditionally, they were viewed as simple barriers for nutrient transport. This review addresses how endothelial cells integrate hormonal and metabolic signals to regulate lipid trafficking, vectorial fatty acid delivery, and depot-specific energy storage, challenging the long-held passive conduit paradigm.
Results
The review highlights that endothelial cells function as crucial peripheral nutrient sensors. It details how endothelial peroxisome proliferator-activated receptor γ (PPARγ), a nuclear receptor, maintains redox balance, supports nitric oxide-dependent perfusion (blood flow), and preserves insulin sensitivity during high-fat feeding. Furthermore, ghrelin signaling through the endothelial GHS-R (Growth Hormone Secretagogue Receptor) promotes triglyceride clearance and lipid uptake into white adipose tissue through a PPARγ-dependent program. This intricate interplay demonstrates the endothelium's active role in metabolic regulation. The most important finding is that the endothelial phenotype, meaning the specific characteristics and functions of these cells, rather than just circulating lipid levels alone, is a primary determinant of organ-level lipid exposure, fundamentally reshaping our understanding of whole-body metabolic homeostasis. This active role means the endothelium integrates diverse signals to fine-tune lipid trafficking, fatty acid delivery, and depot-specific energy storage.
Why It Matters
This reframing of endothelial cells as active regulators of lipid metabolism has significant implications for understanding and treating metabolic disorders. It suggests that targeting specific endothelial functions could offer novel therapeutic strategies beyond traditional approaches. Understanding how endocrine and transcriptional pathways shape endothelial lipid handling may reveal new therapeutic targets for the treatment of obesity, dyslipidemia, and related metabolic diseases. Future research should focus on translating these mechanistic insights into pharmacological interventions and potentially human trials to validate these promising avenues.